LATEST NEWS & INSIGHTS
from nina capital & companies
2021 news
REPLICA ANALYTICS.
Jun 1, 2021
Replica Analytics and Euris Launch Cloud-Based Data Synthesis Platform.
MOVEUP.
May 26, 2021
MoveUP secures €3.65 million in European financing round to support its domestic scale-up and international expansion.
REPLICA ANALYTICS.
May 25, 2021
New Partnership Between Aridhia and Replica Analytics Powers Rapid, Secure and Compliant Use of Health Data.
EARLYSIGHT.
May 25, 2021
Geneva-based EarlySight lands €2 million for its eye diseases diagnostic tool.
ULTROMICS.
May 17, 2021
AI Able to Predict COVID-19 Mortality From Cardiac Ultrasound Measurements.
SUBTLE MEDICAL.
May 5, 2021
Subtle Medical Awarded Breakthrough Patent for Reduced Contrast Agent Dosage in Medical Imaging Exams.
NINA CAPITAL.
Apr 14, 2021
Nina Capital makes the list of "Notable Investors in European Healthtech" in Dealroom's Digital Healthcare: Patient-First report.
SEGMED.
Apr 2, 2021
Segmed, Inc. named one of The Startup Pill Fastest Growing Innovative Artificial Intelligence Startups of 2020.
NINA CAPITAL.
Mar 30, 2021
Aldea Ventures creates ‘hybrid’ European €100M fund to invest both in micro VCs, plus follow-on.
SUBTLE MEDICAL.
Mar 9, 2021
Subtle Medical Launches SubtleMR 2.0 to Expand Improved MRI Capabilities.
NEURESCUE.
Mar 3, 2021
Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company’s Board of Directors.
ELYPTA.
Feb 25, 2021
Start-Up Spotlight: Elypta Targets World’s First Metabolism-Based Early Cancer Diagnosis.
SARCURA.
Feb 23, 2021
Sarcura and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation, tackling manufacturing challenges of cell and gene therapies.
ELYPTA.
Jan 28, 2021
Elypta granted US patent for its liquid biopsy method based on cancer metabolism.
ULTROMICS.
Jan 5, 2021
Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease.
ULTROMICS.
Jan 5, 2021
FDA Clears Ultromics Echocardiography AI for Auto Identification of Coronary Artery Disease.
SEGMED.
Jan 1, 2021
A Secured Cloud-Based Platform That Provides A One-Stop Shop Solution For Medical AI Companies.
TERAPET.
Dec 31, 2020
Terapet together with their world class R&D partners (CERN, Karolinska Institute and Skandion Clinic) are awarded a total of CHF 1’530’000 non-dilutive funds.
